+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Edition of the CRO Market Size Projections: 2018-2023

  • ID: 4803182
  • Report
  • May 2019
  • Region: Global
  • Industry Standard Research (ISR)
Estimated CRO Market Size Projections after Witnessing a fall of 6% in 2018

2018 was a decent, not spectacular, year for CROs. We witnessed year-over-year revenue growth from all the major/public CROs. Yet, the major publicly traded CROs took a pause, along with the rest of the market. Remember, the S&P 500 fell by ~6% in 2018, so the fact that most of the public CROs managed to gain, is a win.

The biopharmaceutical fundamentals stayed intact and CROs were able to take advantage. The publisher's report gives quantitative insight into the perpetual question: “What is the size of the CRO market?” The data provide a thorough, rational perspective for clinical development services segmented by phase, geography, and service line.

ISR utilizes both publicly available information and data obtained through our syndicated primary market research efforts.

Estimated R&D expenditures through 2023

Projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2023, segmented by sponsor type:

  • Large pharma – large molecule
  • Large pharma – small molecule
  • Non-large pharma – large molecule
  • Non-large pharma – small molecule
  • Generic/Specialty
  • Government
  • Private
  • Association/Non-profit
  • Academic

Spending on CRO services segmented by:

  • Geography
  • Service-line
  • Phase I-IV

Major Topics:

  • Overall Market Size and Growth
  • 2019 Geographic Assessment
  • 2019 Service-line Assessment
  • 2019 Development Phase I-IV Assessment
  • 2018-2023 CRO Market Model
  • 2018-2023 CRO Market Model – Growth Rates
  • 2019 Public CRO Market Share
Note: Product cover images may vary from those shown
Adroll
adroll